PET/CT variants and pitfalls in malignant melanoma

(18)F-FDG PET/CT plays an increasingly pivotal role in the staging and post-treatment monitoring of high-risk melanoma patients, augmented by the introduction of therapies, including tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICIs), that have novel modes of action that challe...

Descripción completa

Detalles Bibliográficos
Autores principales: Aide, Nicolas, Iravani, Amir, Prigent, Kevin, Kottler, Diane, Alipour, Ramin, Hicks, Rodney J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724662/
https://www.ncbi.nlm.nih.gov/pubmed/34983677
http://dx.doi.org/10.1186/s40644-021-00440-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724662/
https://www.ncbi.nlm.nih.gov/pubmed/34983677
http://dx.doi.org/10.1186/s40644-021-00440-4

Ejemplares similares